PARP Inhibitor Maintenance Therapy for Pancreatic Cancer With BRCA Mutation from parp Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: At the 2019 Great Debates and Updates in GI Malignancies meeting, Eileen O'Reilly, MD, debated in favor of using PARP inhibitors as maintenance therapy for patients with BRCA mutation–positive pancreatic cancer.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)